IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(47 sites)

Czechia

University Hospital Brno, Brno

University Hospital Hradec Králové, Hradec Králové

University Hospital Olomouc, Olomouc

University Hospital in Ostrava, Ostrava

University Hospital in Pilsen, Pilsen

Germany

Uniklinik RWTH Aachen, Aachen

University Hospital Greifswald, Greifswald

Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle

University Hospital Halle, Halle

University Hospital of Rostock, Rostock

Heinrich-Braun-Klinikum gGmbH, Zwickau

Italy

Policlinico Sant'Orsola, Bologna, BO

IRCCS Ospedale Policlinico San Martino, Genova, GE

Ospedali Riuniti Villa Sofia - Cervello, Palermo, PA

Ospedale S.Spirito - ASL Pescara, Pescara, PE

Ospedale Santa Maria della Misericordia, Perugia, PG

Ospedale Santa Maria delle Croci, Ravenna, RA

Policlinico Tor Vergata, Roma, RM

Policlinico Umberto I, Roma, RM

AOU Città della Salute e della Scienza di Torino, Torino, TO

A. O. Ordine Mauriziano, Torino, TO

Azienda Ospedaliero Universitaria Delle Marche, Ancona

ASST degli Spedali Civili, Brescia

Lithuania

The Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

Portugal

Hospital de Santa Maria, Lisbon

Romania

Fundeni Clinical Institute, Bucharest

Spain

Hospital General Universitario De Albacete, Albacete

Hospital General Universitario Dr. Balmis, Alicante

Hospital Universitari Vall D Hebron, Barcelona

Hospital Clinico Universitario De Valencia, Valencia

Consorcio Hospital General Universitario De Valencia, Valencia

Instituto de Investigación Sanitaria La Fe, Valencia